Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Severe acne in a young girl may indicate underlying hormonal issues.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Spironolactone plus finasteride reduces hirsutism more effectively.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.